Houston Methodist Cancer Center Methodist Cancer Center (2) — Houston, Texas

Houston Methodist Cancer Center Methodist Cancer Center (2) is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Houston Methodist Cancer Center Methodist Cancer Center (2) has participated in 1 clinical trials.

Therapeutic areas: Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Houston Methodist Cancer Center Methodist Cancer Center (2)?

Houston Methodist Cancer Center Methodist Cancer Center (2) has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Houston Methodist Cancer Center Methodist Cancer Center (2) conducted?

Houston Methodist Cancer Center Methodist Cancer Center (2) has 1 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL).

Is Houston Methodist Cancer Center Methodist Cancer Center (2) accredited by Crixeo Health?

Houston Methodist Cancer Center Methodist Cancer Center (2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Houston Methodist Cancer Center Methodist Cancer Center (2)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.